Anaemic patients with acute coronary syndrome (ACS) receive less evidence-based medical therapies than other patients, which likely contribute to their poorer outcomes, an Australian study shows. An analysis of more than 8,000 patients from the CONCORDANCE registry found 21.7% were anaemic on presentation with ACS. These patients were typically older and had more comorbidities than ...
Already a member?
Enter your email to keep reading.